The iPhone 5 Will Give Apple Inc. (AAPL) Another Earnings Record

Apple Inc. (NASDAQ:AAPL) has had a wild ride over the past couple of weeks. On Wednesday, September 12th, the tech giant finally announced the iPhone 5. To say there was hype surrounding Apple’s newest iteration of its über-popular smartphone would be an understatement.

It appears the markets agree.

Apple Inc. (NASDAQ:AAPL)

Over the following two days of trading activity, shares of the company rose nearly 5% to flirt with the $700 mark for the first time in their storied history. In the week since, the stock has risen above this psychological barrier, and currently rests at $700.09 a share.

Now, the news surrounding Apple Inc. (NASDAQ:AAPL) has not been all positive, as fanboys have had to “deal with” early reports that the iPhone 5′s new mapping application is nothing more than a pretty face. Moreover, the device has been criticized by many tech bloggers for failing to live up to their lofty expectations, which included day dreams of features like HD radio and 128GB storage.

While these concerns are justified, it hasn’t slowed down Apple’s party-train one bit. As we reported last week, the company received a record 2 million preorders for the iPhone 5 in its first 24 hours, a level of demand more than twice the size the iPhone 4S had last year. To put these numbers into perspective, recall that Apple sold 37 million units of its newest smartphone in the fourth quarter of 2011 (technically its fiscal Q1), which was also a record total. At the end of this same period, the company reported all-time highs in quarterly revenue ($46.3B) and quarterly EPS ($13.87). In the three months following the public release of its holiday 2011 earnings, shares of Apple rose 31.1%, above the $600 mark for the first time.

Judging by its booming preorder numbers, it’s very likely that these records could be broken once again. Early estimates by Shaw Wu of Sterne Agee place iPhone 5 sales in this year’s holiday quarter at 46.5 million units, and its quite possible that opening weekend sales can eclipse 10 million alone. If these even a fraction of these estimates hold, and the remaining segments of Apple’s revenue remain in-step with historical levels of growth, the company can generate earnings in excess of $15 a share over its next quarter.

At the moment, official EPS forecasts of nearly 40 Wall Street analysts average $15.64 a share, with a range between $14.08 and $18.47. In other words, an EPS on the absolute lowest end of consensus estimates will still be record-setting. Considering the effect that generally positive earnings reports have had on Apple’s stock in the past, its difficult to find any reason not to be bullish on this situation.

Well, here’s one more.

At it’s current market price a shave above $700 a share, Apple Inc. (NASDAQ:AAPL) is undervalued. Yep, you read that right. Despite all of the hubbub surrounding the company at all times, not to mention during the release of arguably its most anticipated product ever, Apple’s shares are cheap.

We can see this by looking at the stock’s Price-to-Earnings ratio (16.5X), which is below Google Inc. (NASDAQ:GOOG) at 21.8X, and Apple’s own 5-year historical average of 21.9X. More importantly, when forward-looking estimates are used, Apple also trades at a lower earnings multiple (13.3X) than the forward P/E of Google (14.9X). Interestingly, Microsoft Corporation (NASDAQ:MSFT) is trading at cheaper trailing (15.6X) and forward (9.5X) P/Es than the Cupertino-based company, but the true light of Apple’s undervaluation can be seen when earnings growth is factored into the equation.

The PEG ratio, which indicates how investors are valuing a company’s expected EPS growth, is particularly low when looking at Apple. With a PEG of 0.76, it is trading at nearly a 25% discount to what is considered to be a “fair” valuation, and this metric is also below Google (1.29) and Microsoft (1.78), and lower than more loosely associated peers like Dell Inc. (NASDAQ:DELL) at 1.25, and International Business Machines Corp. (NYSE:IBM) at 1.41.

As Apple Inc. (NASDAQ:AAPL) continues its maturity into even more of an omnipresent force in the technological world, its growth will undoubtedly slow, and long-range estimates are already predicting such an event. Though the company’s EPS growth has averaged 65.0% annually over the past five years, early consensus places this growth to average 21.5% a year over the next half-decade. Though this estimated growth is below historical levels, it is still above the likes of Google (16.8%), Microsoft (8.8%), Dell (4.9%), and IBM (10.6%). It appears that the markets are over-discounting Apple’s slowing growth, and even if its holiday sales remain flat from 2011 totals, investors can still expect solid appreciation over the next 6-12 months.

Fortunately for the millions of Apple Inc. (NASDAQ:AAPL) bulls out there, it is reasonable to expect the iPhone 5 to outsell the 4GS over the remainder of 2012. If this occurs, and more sales records are broken, it’s a strong possibility that the stock could crack the quadruple digits. As mentioned in “Apple (AAPL) Can Get Past $1,000,” a successful deal with China Mobile Ltd. (NYSE:CHL) will give the company access to nearly 700 million untapped mobile phone users, or 70% of Chinese market.

If Apple can reach an agreement with China Mobile while selling 40 million-plus iPhone 5 units over the next quarter, investors can expect a very merry Christmas.

The hedge fund industry is definitely in agreement with this outlook, as 140 funds held shares of Apple in their 13F portfolios at the end of Q2. This total compares very favorably to its tech competitors like Google (113), Microsoft (97), Dell (35), and IBM (43). Some of the most notable Apple bulls are Chase Coleman of Tiger Global Management, David Einhorn of Greenlight Capital, and Philippe Laffont of Coatue Management. For a complete look at hedge funds’ sentiment toward Apple Inc. (NASDAQ:AAPL), continue reading here.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!